title: A SPRINT to the finish, or just the beginning? Implications of the SPRINT results for nephrologists.
abstract: The Systolic Blood Pressure Intervention Trial (SPRINT) demonstrated a significant reduction in major cardiovascular events and all-cause mortality with intensive blood pressure control in older individuals at high cardiovascular risk, including patients with chronic kidney disease and mild proteinuria. Nephrologists should consider the SPRINT results when determining the optimal blood pressure target for patients with chronic kidney disease.
authors.affiliation: Wake Forest School of Medicine, Section on Nephrology, Winston-Salem, North Carolina, USA. Electronic address: mrocco@wakehealth.edu.
authors.forename: Michael V
authors.initials: MV
authors.lastname: Rocco
authors.affiliation: Division of Nephrology and Hypertension, University of Utah, Salt Lake City, Utah, USA.
authors.forename: Alfred K
authors.initials: AK
authors.lastname: Cheung
mesh_terms: D000959:Antihypertensive Agents / Q000008:administration & dosage*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000401:mortality; D009398:Nephrology; D014481:United States / Q000453:epidemiology
chemical_list: D000959:Antihypertensive Agents